Invivogen
Menu

293-Dual™ hSTING-H232 Cells

Product Unit size Cat. code Docs. Qty. Price

293-Dual™ hSTING-H232 Cells

Dual IRF and IFN-β reporter 293 cells expressing H232 isoform of human STING (R232H)

Show product

3-7 x 10e6 cells

293d-h232
+-
$1,457

293-Dual™ hSTING-H232 Cells (ISG-SEAP/KI-[IFN-b]Lucia)

293-Dual™ hSTING-H232 (ISG/KI-IFNb) cells were generated from 293-Dual™ Null (ISG/KI-IFNb) cells by stable transfection of the H232 isoform of human STING (hSTING). R232H has been identified as a natural variant allele of STING occurring in ~14% of the human population [1].

The H232 isoform contains a single amino acid substitution R232H. This isoform has a diminished response to bacterial and metazoan CDNs when compared to the prevalent R232 hSTING allele [1, 2].

H232 has been the most commonly used hSTING variant in published structural studies.

293-DualhSTING-H232 (ISG/KI-IFNb) cells are resistant to blasticidinhygromycin, and Zeocin® .

 

References:

1. Yi G. et al., 2013. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. PLoS One. 8(10):e77846.
2. Diner E. et al., 2013. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 3(5):1355-61.

Figures

IRF induction (SEAP reporter)
IRF induction (SEAP reporter)

Dose-responses of 293-Dual™ hSTING H232 cells stimulated with 2’3’-cGAMP, 3’3’-cGAMP and DMXAA. After 24h incubation, IRF induction was assessed by measuring the levels of SEAP using QUANTI‑Blue™ and by reading the optical density (OD) at 655 nm.

IFN-β induction (Lucia luciferase reporter)
IFN-β induction (Lucia luciferase reporter)

293-Dual™ hSTING H232 cells were stimulated with 3’3’-cGAMP (30 μg/ml), 3’3’-cGAMP Fluorinated (10 μg/ml), 2’3’-cGAMP (30 μg/ml,) 2’3’-cGAM(PS)2 (Rp,Rp) (10 μg/ml), DMXAA (30 μg/ml) and human IFN-α (30 IU/ml). After 24h incubation, IFN-β induction was assessed by measuring the levels of Lucia luciferase using QUANTI-Luc™ and by reading the relative light units (RLUs) in a luminometer. The IFN-β response is expressed as a fold induction (calculated by dividing the RLUs for the treated cells by the RLUs for the untreated cells).

Back to the top

Specifications

Antibiotic resistance: blasticidinhygromycin, and Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Quality Control:

  • Reporter activity has been validated by stimulating the cells with human interferon-β (hIFN-β) and IRF3 activators, such as c-di-AMP and cGAMP.
  • The biallelic replacement of the hIFN-β coding sequence with the Lucia luciferase open reading frame (ORF) has been verified by PCR and sequencing.
  • The inability to produce IFN-β has been confirmed by ELISA.
  • The cell line stability for 20 passages following thawing has been verified.

Guaranteed mycoplasma-free.

 

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 3-7 x 106 of 293-Dual™ hSTING-H232 (ISG/KI-IFNb) cells in a cryovial or shipping flask
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 ml of Hygromycin (100 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)
  • 1 tube of QUANTI-Luc™ 4 Reagent, a Lucia luciferase detection reagent (sufficient to prepare 25 ml)

Dry ice Shipped on dry ice (Europe, USA, Canada, and some areas in Asia)

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top

Notification:  This product is for internal research use only. Additional rights may be available. Please visit InvivoGen’s Terms and Conditions.

Customer Service
& Technical Support
Shopping cart is empty